Brief: Adaptimmune Reports First Quarter Financial Results

Adaptimmune Therapeutics

09/05/2022 12:42

May 9 (Reuters) - Adaptimmune Therapeutics PLC  ADAP.O :
    * ADAPTIMMUNE REPORTS FIRST QUARTER FINANCIAL RESULTS AND
BUSINESS
UPDATE
    * REVENUE FOR THREE MONTHS ENDED MARCH 31, 2022 WAS $3.6
MILLION,
COMPARED TO $0.4 MILLION FOR SAME PERIOD IN 2021
    * QTRLY LOSS PER SHARE $0.05
    * AS OF MARCH 31, 2022, ADAPTIMMUNE HAD CASH AND CASH
EQUIVALENTS
OF $89.5 MILLION
    * Q1 EARNINGS PER SHARE VIEW $-0.22, REVENUE VIEW $3.3
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3R02N4 
Further company coverage:  ADAP.O 

 ((Reuters.Briefs@thomsonreuters.com;))